
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy in autoimmune encephalitis
Benjamin Trewin, Isaak Freeman, Sudarshini Ramanathan, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 399-414
Closed Access | Times Cited: 19
Benjamin Trewin, Isaak Freeman, Sudarshini Ramanathan, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 399-414
Closed Access | Times Cited: 19
Showing 19 citing articles:
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Origins and immunopathogenesis of autoimmune central nervous system disorders
Sudarshini Ramanathan, Fabienne Brilot, Sarosh Irani, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 3, pp. 172-190
Closed Access | Times Cited: 37
Sudarshini Ramanathan, Fabienne Brilot, Sarosh Irani, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 3, pp. 172-190
Closed Access | Times Cited: 37
Novel Approaches to Treatment of Immune-Mediated Chronic Intestinal Pseudo-Obstruction
Andreu Vilaseca, Paula Arranz, Arnau Llauradó, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Closed Access | Times Cited: 1
Andreu Vilaseca, Paula Arranz, Arnau Llauradó, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Closed Access | Times Cited: 1
Gut microbiome-based therapies for alleviating cognitive impairment: state of the field, limitations, and future perspectives
Linli Bu, Chen Wang, Junying Bai, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1116-1134
Closed Access | Times Cited: 5
Linli Bu, Chen Wang, Junying Bai, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1116-1134
Closed Access | Times Cited: 5
The clinical relevance of MOG antibody testing in cerebrospinal fluid
Molly Reynolds, Irene Tan, Kristy Nguyen, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 9, pp. 2514-2519
Open Access | Times Cited: 5
Molly Reynolds, Irene Tan, Kristy Nguyen, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 9, pp. 2514-2519
Open Access | Times Cited: 5
Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report
Xiaoyan Lu, Hangfei Wu, Yadi Tan, et al.
International Medical Case Reports Journal (2025) Vol. Volume 18, pp. 105-109
Open Access
Xiaoyan Lu, Hangfei Wu, Yadi Tan, et al.
International Medical Case Reports Journal (2025) Vol. Volume 18, pp. 105-109
Open Access
Resolution of anti-LGI1-associated autoimmune encephalitis in a patient after treatment with efgartigimod
Feng Zhu, Wanfen Wang, Chuan-Hua Ma, et al.
Journal of Neurology (2024) Vol. 271, Iss. 9, pp. 5911-5915
Closed Access | Times Cited: 3
Feng Zhu, Wanfen Wang, Chuan-Hua Ma, et al.
Journal of Neurology (2024) Vol. 271, Iss. 9, pp. 5911-5915
Closed Access | Times Cited: 3
Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor
Dong Li, Teng Huang, Fangyuan Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Dong Li, Teng Huang, Fangyuan Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Mapping the global research landscape and trends of autoimmune encephalitis: A bibliometric analysis
Song Ouyang, Zhenchu Tang, Weiwei Duan, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26653-e26653
Open Access | Times Cited: 2
Song Ouyang, Zhenchu Tang, Weiwei Duan, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26653-e26653
Open Access | Times Cited: 2
Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin
Zhangliang Lin, Feng Zhou, Li-Li Ni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Zhangliang Lin, Feng Zhou, Li-Li Ni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
MONOCLONAL ANTIBODY THERAPY IN AUTOANTIBODY-ASSOCIATED PSYCHOTIC DISORDERS AND SCHIZOPHRENIA: NARRATIVE REVIEW OF PAST AND CURRENT CLINICAL TRIALS
Niels Hansen, Berend Malchow
Psychiatria Danubina (2023) Vol. 35, Iss. 1, pp. 8-15
Open Access | Times Cited: 6
Niels Hansen, Berend Malchow
Psychiatria Danubina (2023) Vol. 35, Iss. 1, pp. 8-15
Open Access | Times Cited: 6
Autoimmune and paraneoplastic seizures
Barbara Wagner, Sarosh Irani
Handbook of clinical neurology (2024), pp. 151-172
Closed Access | Times Cited: 1
Barbara Wagner, Sarosh Irani
Handbook of clinical neurology (2024), pp. 151-172
Closed Access | Times Cited: 1
S100A6 participates in initiation of autoimmune encephalitis and is under epigenetic control
Chih‐Hsiang Lin, Sung‐Chou Li, Ming‐Hong Lin, et al.
Brain and Behavior (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Chih‐Hsiang Lin, Sung‐Chou Li, Ming‐Hong Lin, et al.
Brain and Behavior (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness
Zhuowei Gong, Dayuan Lao, Fang Huang, et al.
Patient Related Outcome Measures (2023) Vol. Volume 14, pp. 181-192
Open Access | Times Cited: 2
Zhuowei Gong, Dayuan Lao, Fang Huang, et al.
Patient Related Outcome Measures (2023) Vol. Volume 14, pp. 181-192
Open Access | Times Cited: 2
Is anti-NMDA receptor encephalitis real? II. Therapeutic challenges
Evgeny V. Snedkov, И.А. Волчек, Ilia V. Lemeshev
Neurology Bulletin (2024) Vol. LVI, Iss. 1, pp. 83-94
Closed Access
Evgeny V. Snedkov, И.А. Волчек, Ilia V. Lemeshev
Neurology Bulletin (2024) Vol. LVI, Iss. 1, pp. 83-94
Closed Access
RESILIENCE (Retrospective Linkage Study of Autoimmune Encephalitis): protocol for an Australian retrospective cohort study of outcomes in autoimmune encephalitis using data linkage techniques
Amy J. Halliday, Katrina A. Lambert, Christine Bundell, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e084664-e084664
Open Access
Amy J. Halliday, Katrina A. Lambert, Christine Bundell, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e084664-e084664
Open Access
Psychiatrische Autoimmunenzephalitis – Diagnose und therapeutische Ansätze
Niels Hansen, Daniel Lüdecke, Hannah Benedictine Maier, et al.
PSYCH up2date (2023) Vol. 17, Iss. 01, pp. 13-28
Open Access | Times Cited: 1
Niels Hansen, Daniel Lüdecke, Hannah Benedictine Maier, et al.
PSYCH up2date (2023) Vol. 17, Iss. 01, pp. 13-28
Open Access | Times Cited: 1
Navigating the diagnostic and therapeutic complexities of autoimmune encephalitis
Thashi Chang
Sri Lanka Journal of Neurology (2023) Vol. 10, Iss. 2, pp. 33-41
Open Access | Times Cited: 1
Thashi Chang
Sri Lanka Journal of Neurology (2023) Vol. 10, Iss. 2, pp. 33-41
Open Access | Times Cited: 1
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?
Mark Kelly, Sarosh Irani
European Journal of Neurology (2023) Vol. 30, Iss. 5, pp. 1167-1169
Open Access
Mark Kelly, Sarosh Irani
European Journal of Neurology (2023) Vol. 30, Iss. 5, pp. 1167-1169
Open Access